Cardiovascular & Hematological Disorders-Drug Targets

Editor-in-Chief

ISSN (Print): 1871-529X
ISSN (Online): 2212-4063

Latest Issue: Volume 19 , Issue 3 , 2019

Back Journal Home
Topics Covered

2 Topics

View
Covered Diseases

1 Diseases

View

Aims & Scope

Cardiovascular & Hematological Disorders-Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in cardiovascular and hematological disorders e.g. disease specific proteins, receptors, enzymes, genes. Each issue of the journal contains a series of in-depth/mini reviews, original research articles, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cardiovascular and hematological disorders. As the discovery, identification, characterization and validation of novel human drug targets for cardiovascular and hematological drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Abstracted/Indexed in


MEDLINE/PubMed/Index Medicus, BIOSIS, BIOSIS Previews, BIOSIS Reviews Reports and Meetings, Scopus, EMBASE/Excerpta Medica, Chemical Abstracts Service/SciFinder, Cambridge Scientific Abstracts (CSA)/ProQuest, ChemWeb, Google Scholar, BIOBASE, MediaFinder®-Standard Periodical Directory, Genamics JournalSeek, PubsHub, J-Gate, CNKI Scholar, Suweco CZ, TOC Premier, EBSCO, British Library, Ulrich's Periodicals Directory and JournalTOCs.

Special Offers

Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.

30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.

Announcements
Endorsement(s)
"The journal presents the latest developments in various areas of medicinal chemistry. I strongly recommend it to scientists working in the field."

Garry X. Shen
Univ. of Manitoba, Canada
Authors' Comments

My experience with Bentham Science Publishers has been great and I am looking forward to continue contributions for future publications.


Muhammad Ali Chaudhry
(Aultman Hospital, United States.)

Has contributed: The intriguing occurrence of Segmental Arterial Mediolysis; Case report and concise literature review.